FDA: fluvoxamine doesn't treat COVID-19 — and here's 27 pages why - The Verge

The FDA released a document with information about its decision to not authorize fluvoxamine to treat COVID-19. It’s unusual for the agency to publicize its reasoning for rejecting a drug.

The FDA usually doesnt say why it rejects drugs Jason Armond / Los Angeles Times via Getty Images When the US Food and Drug Administration rejected an antidepressant as a treatment for COVID-19 on … [+2393 chars]

full article...